EarliPoint Health Launches Skill Illustrator™ to Help Providers Translate Assessment Data into Actionable Developmental Insights.

Read Release →

From Access to Inclusion: Redesigning Communities for Individuals with Autism

In this episode of the EarliPoint Exchange, Dr. Cheryl Tierney and Kirsten Yurich, BCBA, are joined by Dr. Wendy Ross, a nationally recognized leader in advancing inclusive care and community access for individuals with autism.

This conversation moves beyond traditional clinical settings to explore how inclusion is built across everyday environments. Dr. Ross, a behavioral pediatrician and the director of Jefferson Health’s Center for Autism and Neurodiversity, shares her work designing sensory-friendly experiences in children’s museums, partnering with major sports organizations and the airline industry to create more accessible fan experiences, and guiding authentic autism representation in media, including her collaboration with the hit show The Pitt on the character “Mel.”

Together,we will examine how healthcare providers, community institutions, and systems leaders can move from awareness to action—creating environments that are not only accommodating, but truly welcoming and supportive for neurodiverse individuals and their families.

The webinar will be held on June 24, 2026, from 12PM-1PM, and includes 1 BACB® GEN CEU. Attendance is included free with a BehaviorLive subscription, and registrants will also have access to the recorded session on-demand for CEUs.

Learning Objectives

  • Describe key barriers to community access for individuals with autism across healthcare, recreational, and public settings.
  • Identify practical strategies for implementing sensory-friendly and inclusive practices in community environments such as museums, sports venues, and public spaces.
  • Explain the role of clinicians in advocating for and partnering with community organizations to expand inclusion beyond the clinical setting.
  • Evaluate how authentic representation and lived-experience-informed design can improve outcomes and experiences for individuals with autism and their families.

Register now to reserve your spot and explore how groundbreaking research in eye-tracking is advancing the future of autism diagnosis and assessment.

Pete Polgar

VP of Marketing

Pete Polgar is the Vice President of Marketing at Earlipoint. He leads the company’s marketing strategy, focusing on brand positioning, demand generation, and digital growth. With a background in performance marketing and content strategy, Pete works on aligning marketing initiatives with business development to drive measurable results and expand Earlipoint’s market presence.

Latest News

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder